These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37114202)

  • 1. Novel Monitoring and Dose Adjustment of Argatroban, a Direct Thrombin Inhibitor, to Maintain Therapeutic Anticoagulation in a Patient With Antiphospholipid Antibody Syndrome, Heparin-Induced Thrombocytopenia, and COVID-19 Pneumonia.
    Ryan CE; Newman KA; Roberts RJ; Frydman GH; Rosovsky RP
    Crit Care Explor; 2023 Apr; 5(4):0903. PubMed ID: 37114202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of intravenous direct thrombin inhibitor monitoring tests: Correlation with plasma concentrations and clinical outcomes in hospitalized patients.
    Beyer JT; Lind SE; Fisher S; Trujillo TC; Wempe MF; Kiser TH
    J Thromb Thrombolysis; 2020 Feb; 49(2):259-267. PubMed ID: 31559512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring Direct Thrombin Inhibitors With Calibrated Diluted Thrombin Time vs Activated Partial Thromboplastin Time in Pediatric Patients.
    Hasan RA; Pak J; Kirk CJ; Friedland-Little JM; Chandler WL
    Am J Clin Pathol; 2023 Jan; 159(1):60-68. PubMed ID: 36351044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring of Argatroban and Lepirudin: What is the Input of Laboratory Values in "Real Life"?
    Seidel H; Kolde HJ
    Clin Appl Thromb Hemost; 2018 Mar; 24(2):287-294. PubMed ID: 28320219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative monitoring of argatroban using plasma-diluted thrombin time.
    Wanat MA; Hart SR; Putney D; Liebl MG; Chandler W
    Ann Pharmacother; 2013 Apr; 47(4):e18. PubMed ID: 23482736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD.
    Dager WE; White RH
    Ann Pharmacother; 2003 Sep; 37(9):1232-6. PubMed ID: 12921505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caution in Using the Activated Partial Thromboplastin Time to Monitor Argatroban in COVID-19 and Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT).
    Guy S; Kitchen S; Makris M; M Maclean R; Saccullo G; Vanveen JJ
    Clin Appl Thromb Hemost; 2021; 27():10760296211066945. PubMed ID: 34905962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the aPTT with alternative tests for monitoring direct thrombin inhibitors in patient samples.
    Lind SE; Boyle ME; Fisher S; Ishimoto J; Trujillo TC; Kiser TH
    Am J Clin Pathol; 2014 May; 141(5):665-74. PubMed ID: 24713737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limitation of the activated partial thromboplastin time as a monitoring method of the direct thrombin inhibitor argatroban.
    Guy S; Kitchen S; Maclean R; Van Veen JJ
    Int J Lab Hematol; 2015 Dec; 37(6):834-43. PubMed ID: 26305560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of argatroban and bivalirudine in patients with suspected heparin-induced thrombocytopenia.
    Vo QA; Lin JK; Tong LM
    Ann Pharmacother; 2015 Feb; 49(2):178-84. PubMed ID: 25515865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-Induced Thrombocytopenia in Infants after Heart Surgery.
    Abdillah JN; Hu Q; Chen X; Chen X; Zhou W; Luo W; Huang L
    Thorac Cardiovasc Surg; 2019 Jan; 67(1):21-27. PubMed ID: 29605959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory Monitoring of Parenteral Direct Thrombin Inhibitors.
    Van Cott EM; Roberts AJ; Dager WE
    Semin Thromb Hemost; 2017 Apr; 43(3):270-276. PubMed ID: 28052306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Argatroban dosing of patients with heparin-induced thrombocytopenia and an elevated aPTT due to antiphospholipid antibody syndrome.
    Pendleton R; Wheeler MM; Rodgers GM
    Ann Pharmacother; 2006 May; 40(5):972-6. PubMed ID: 16569813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of bivalirudin and argatroban for the management of heparin-induced thrombocytopenia.
    Skrupky LP; Smith JR; Deal EN; Arnold H; Hollands JM; Martinez EJ; Micek ST
    Pharmacotherapy; 2010 Dec; 30(12):1229-38. PubMed ID: 21114390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing direct thrombin inhibitors using aPTT, ecarin clotting times, and thrombin inhibitor management testing.
    Gosselin RC; King JH; Janatpour KA; Dager WE; Larkin EC; Owings JT
    Ann Pharmacother; 2004 Sep; 38(9):1383-8. PubMed ID: 15238620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring of argatroban and lepirudin anticoagulation in critically ill patients by conventional laboratory parameters and rotational thromboelastometry - a prospectively controlled randomized double-blind clinical trial.
    Beiderlinden M; Werner P; Bahlmann A; Kemper J; Brezina T; Schäfer M; Görlinger K; Seidel H; Kienbaum P; Treschan TA
    BMC Anesthesiol; 2018 Feb; 18(1):18. PubMed ID: 29426286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory methods for monitoring argatroban in heparin-induced thrombocytopenia.
    Guy S; Kitchen S; Hopkins B; Chunara Z; Stephenson-Brown A; van Veen JJ
    Int J Lab Hematol; 2022 Apr; 44(2):399-406. PubMed ID: 34755452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Argatroban Anticoagulation for Adult Extracorporeal Membrane Oxygenation: A Systematic Review.
    Geli J; Capoccia M; Maybauer DM; Maybauer MO
    J Intensive Care Med; 2022 Apr; 37(4):459-471. PubMed ID: 33653194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged anticoagulation after discontinuation of argatroban and warfarin therapy in an obese patient with heparin-induced thrombocytopenia.
    Shapiro NL; Durr EA; Krueger CD
    Pharmacotherapy; 2006 Dec; 26(12):1806-10. PubMed ID: 17125442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of renal function on argatroban therapy in heparin-induced thrombocytopenia.
    Guzzi LM; McCollum DA; Hursting MJ
    J Thromb Thrombolysis; 2006 Dec; 22(3):169-76. PubMed ID: 17103051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.